Société de Therapeutique Marocaine S.A. (CBSE:SOT)

Market Cap	13.31B +99.9%
Revenue (ttm)	3.04B +15.5%
Net Income	345.28M +25.8%
EPS	47.96 +25.9%
Shares Out	7.61M
PE Ratio	37.15
Forward PE	33.59
Dividend	28.00 (1.60%)
Ex-Dividend Date	Jun 20, 2025

Volume	36
Average Volume	421
Open	1,805.00
Previous Close	1,799.00
Day's Range	1,750.00 - 1,805.00
52-Week Range	940.10 - 1,950.00
Beta	-0.14
RSI	41.54
Earnings Date	Apr 21, 2026

About CBSE:SOT

Société de Therapeutique Marocaine S.A., a pharmaceutical company, engages in the manufacturing of licensed medicines in Morocco. It offers products in various therapeutic areas, such as allergology, oncology, cardiology, dental, dermatology, endocrinology, gastroenterology, gynecology, ophthalmology, ENT, pediatric, pulmonology, reanimation, rheumatology, central nervous system (CNS), and urology, as well as antibiotics and generics. The company also provides its products in various forms, including tablets, capsules, pouches, syrups, suspensi...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 1,219
• Stock Exchange: Casablanca Stock Exchange
• Ticker Symbol: SOT

Financial Performance

In 2024, CBSE:SOT's revenue was 2.82 billion, an increase of 13.27% compared to the previous year's 2.49 billion. Earnings were 315.29 million, an increase of 19.99%.